{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:07:48Z","timestamp":1789117668454,"version":"build-2803163510"},"reference-count":32,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background and Objectives: Visceral pleural invasion (VPI) up-classifies non-small cell lung cancer (NSCLC) tumors measuring \u22643 cm from T1 to T2; however, whether this stage migration translates into worse survival in pathologically node-negative disease remains uncertain. This study evaluated the prognostic impact of VPI on overall survival (OS) and progression-free survival (PFS) in this selected population. Materials and Methods: This retrospective single-center cohort study included patients who underwent surgical resection for pathologically node-negative NSCLC with tumors \u2264 3 cm between 2015 and 2021. In the primary analysis, patients with PL0 were compared with those with PL1\u2013PL2, whereas PL3 cases were excluded from the primary comparison and evaluated only in exploratory analyses. Survival outcomes were assessed using Kaplan\u2013Meier analysis and univariable and multivariable Cox regression models. Results: A total of 241 patients were included in the overall cohort (PL0, n = 179; PL1, n = 48; PL2, n = 9; PL3, n = 5). After exclusion of PL3 from the primary analysis, 236 patients remained, including 179 with PL0 and 57 with PL1\u2013PL2. During follow-up, 58 deaths and 81 PFS events occurred in the primary analytic cohort. Kaplan\u2013Meier analysis showed no significant differences between PL0 and PL1\u2013PL2 in OS (log-rank p = 0.655) or PFS (log-rank p = 0.904). In multivariable analysis, VPI was not independently associated with OS (HR 0.785, 95% CI 0.389\u20131.582; p = 0.498) or PFS (HR 0.908, 95% CI 0.507\u20131.624; p = 0.744). Increasing age was independently associated with worse OS and PFS, whereas male sex and pneumonectomy were independently associated with worse OS. Conclusions: In surgically treated patients with pathologically node-negative NSCLC and tumors \u2264 3 cm, VPI defined as PL1\u2013PL2 was not independently associated with OS or PFS. These findings suggest that the prognostic implications of VPI-driven up-classification may be context-dependent and should be interpreted together with other clinicopathological factors.<\/jats:p>","DOI":"10.3390\/cancers18182944","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:17:42Z","timestamp":1789114662000},"page":"2944","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Impact of Visceral Pleural Invasion in Node-Negative Non-Small Cell Lung Cancer with Tumors \u2264 3 cm"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0050-0668","authenticated-orcid":false,"given":"Ezgi G\u00fcrel","family":"Akan","sequence":"first","affiliation":[{"name":"Department of Chest Diseases, Ankara Atat\u00fcrk Sanatorium Training and Research Hospital, 06290 Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4087-7048","authenticated-orcid":false,"given":"P\u0131nar","family":"Ak\u0131n Kabalak","sequence":"additional","affiliation":[{"name":"Department of Chest Diseases, Ankara Atat\u00fcrk Sanatorium Training and Research Hospital, 06290 Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"given":"Suna","family":"Kavurgac\u0131","sequence":"additional","affiliation":[{"name":"Department of Chest Diseases, Ankara Atat\u00fcrk Sanatorium Training and Research Hospital, 06290 Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Tuba","family":"\u0130nal Cengiz","sequence":"additional","affiliation":[{"name":"Department of Chest Diseases, Ankara Atat\u00fcrk Sanatorium Training and Research Hospital, 06290 Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Funda","family":"Demira\u011f","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ankara Atat\u00fcrk Sanatorium Training and Research Hospital, 06290 Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"}]},{"given":"Hakan","family":"Nomeno\u011flu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Ankara Atat\u00fcrk Sanatorium Training and Research Hospital, 06290 Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5580-4741","authenticated-orcid":false,"given":"Hasan","family":"\u0130bi\u015f","sequence":"additional","affiliation":[{"name":"Department of Chest Diseases, Ankara Atat\u00fcrk Sanatorium Training and Research Hospital, 06290 Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"}]},{"given":"\u00dclk\u00fc","family":"Y\u0131lmaz","sequence":"additional","affiliation":[{"name":"Department of Chest Diseases, Ankara Atat\u00fcrk Sanatorium Training and Research Hospital, 06290 Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.21037\/qims.2018.08.02","article-title":"The 8th lung cancer TNM classification and clinical staging system: Review of the changes and clinical implications","volume":"8","author":"Lim","year":"2018","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.chest.2024.05.026","article-title":"The proposed ninth edition TNM classification of lung cancer","volume":"166","author":"Detterbeck","year":"2024","journal-title":"Chest"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.21037\/jtd.2019.06.32","article-title":"Visceral pleural invasion in T1 tumors (\u22643 cm), particularly T1a, in the eighth tumor-node-metastasis classification system for non-small cell lung cancer: A population-based study","volume":"11","author":"Zhang","year":"2019","journal-title":"J. Thorac. Dis."},{"key":"ref_4","first-page":"138","article-title":"Lung cancer\u2014Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Asamura","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Son, J.W., Lee, J., Jeon, J.H., Cho, S., Jung, W., Shih, B.C.H., Kim, K., and Jheon, S. (2024). Validation of IASLC 9th edition TNM classification for lung cancer: Focus on N descriptor. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-13139-z"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jtho.2024.02.011","article-title":"The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for revision of the TNM stage groups in the forthcoming (ninth) edition of the TNM classification for lung cancer","volume":"19","author":"Nishimura","year":"2024","journal-title":"J. Thorac. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.annonc.2025.08.003","article-title":"Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"36","author":"Zer","year":"2025","journal-title":"Ann. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1378\/chest.14-2765","article-title":"The impact of visceral pleural invasion in node-negative non-small cell lung cancer: A systematic review and meta-analysis","volume":"148","author":"Jiang","year":"2015","journal-title":"Chest"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1378\/chest.13-0394","article-title":"Visceral pleural invasion does not affect recurrence or overall survival among patients with lung adenocarcinoma \u2264 2 cm: A proposal to reclassify T1 lung adenocarcinoma","volume":"144","author":"Nitadori","year":"2013","journal-title":"Chest"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1378\/chest.11-2552","article-title":"Prognostic significance of the extent of visceral pleural invasion in completely resected node-negative non-small cell lung cancer","volume":"142","author":"Hung","year":"2012","journal-title":"Chest"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/1759-7714.12424","article-title":"Extent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer","volume":"8","author":"Seok","year":"2017","journal-title":"Thorac. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1097\/JTO.0b013e31818e0d9f","article-title":"Visceral pleural invasion: Pathologic criteria and use of elastic stains: Proposal for the 7th edition of the TNM classification for lung cancer","volume":"3","author":"Travis","year":"2008","journal-title":"J. Thorac. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.chest.2021.03.022","article-title":"Modification of pathologic T classification for non-small cell lung cancer with visceral pleural invasion: Data from 1,055 cases of cancers \u2264 3 cm","volume":"160","author":"Liang","year":"2021","journal-title":"Chest"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Fang, P., Cheng, J., Lu, Y., and Fu, L. (2022). Rethinking the selection of pathological T-classification for non-small-cell lung cancer in varying degrees of visceral pleural invasion: A SEER-based study. Front. Surg., 9.","DOI":"10.3389\/fsurg.2022.902710"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ruan, Z., Zhuo, X., and Xu, C. (2024). Diagnosis, treatment, and prognosis of stage IB non-small cell lung cancer with visceral pleural invasion. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1310471"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/jamaoncol.2024.2491","article-title":"Recurrence of non-small cell lung cancer with visceral pleural invasion: A secondary analysis of a randomized clinical trial","volume":"10","author":"Altorki","year":"2024","journal-title":"JAMA Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ejso.2023.01.022","article-title":"The location of visceral pleural invasion in stage IB patients with non-small cell lung cancer: Comparison and prognosis","volume":"49","author":"Ren","year":"2023","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"101205","DOI":"10.1016\/j.currproblcancer.2025.101205","article-title":"Updated perspectives on visceral pleural invasion in non-small cell lung cancer: A propensity score-matched analysis of the SEER database","volume":"56","author":"Liu","year":"2025","journal-title":"Curr. Probl. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.athoracsur.2011.03.021","article-title":"Impact of laterality on early and late survival after pneumonectomy","volume":"92","author":"Fernandez","year":"2011","journal-title":"Ann. Thorac. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.21037\/tcr-20-1995","article-title":"The prognosis of small-sized non-small cell lung cancer with visceral pleural invasion after sublobar resection","volume":"9","author":"Choi","year":"2020","journal-title":"Transl. Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.cllc.2024.11.007","article-title":"Lobectomy is not associated with improved survival as compared to segmentectomy in early-stage lung cancer patients with visceral pleural invasion","volume":"26","author":"Whitehorn","year":"2025","journal-title":"Clin. Lung Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"875","DOI":"10.21037\/jtd-23-936","article-title":"Impact of adjuvant chemotherapy on patients with stage IB non-small cell lung cancer with visceral pleural invasion","volume":"16","author":"Kim","year":"2024","journal-title":"J. Thorac. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.athoracsur.2021.04.108","article-title":"Adjuvant chemotherapy for high-risk pathologic stage I non-small cell lung cancer","volume":"113","author":"Tsutani","year":"2022","journal-title":"Ann. Thorac. Surg."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Lee, P.-H., Chiang, C.-J., Tseng, J.-S., Zheng, Z.-R., Chen, K.-C., Chu, C.-H., Huang, Y.-H., Hsu, K.-H., Lee, W.-C., and Yang, T.-Y. (2023). Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1096683"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s00432-020-03276-w","article-title":"Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion","volume":"146","author":"Xie","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3904\/kjim.2020.011","article-title":"Clinical efficacy of adjuvant chemotherapy in stage IB (<4 cm) non-small cell lung cancer patients with high-risk factors","volume":"37","author":"Choi","year":"2022","journal-title":"Korean J. Intern. Med."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Huang, W., Deng, H.-Y., Lin, M.-Y., Xu, K., Zhang, Y.-X., Yuan, C., and Zhou, Q. (2022). Treatment modality for stage IB peripheral non-small cell lung cancer with visceral pleural invasion and \u22643 cm in size. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.830470"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"ezab498","DOI":"10.1093\/ejcts\/ezab498","article-title":"Adjuvant chemotherapy for visceral pleural invasion in 3\u20134-cm non-small-cell lung cancer improves survival","volume":"62","author":"Wightman","year":"2022","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"11262","DOI":"10.21037\/jtd-2025-1858","article-title":"Grade-driven adjuvant chemotherapy benefit in high-risk stage IB NSCLC: A retrospective cohort study","volume":"17","author":"Tao","year":"2025","journal-title":"J. Thorac. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cllc.2024.11.001","article-title":"The Potential of Basal F-18-FDG PET\/CT in Evaluating Prognosis and Benefit From Adjuvant Chemotherapy After Tumor Resection of Stage IB (T2, \u22643 cm with VPI, N0, M0) NSCLC","volume":"26","author":"Lei","year":"2025","journal-title":"Clin. Lung Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e560","DOI":"10.1016\/j.cllc.2025.07.001","article-title":"Lymphovascular invasion is a predictor of postoperative recurrence or death in stage I non-small-cell lung cancer (NSCLC)","volume":"26","author":"Locke","year":"2025","journal-title":"Clin. Lung Cancer"},{"key":"ref_32","unstructured":"Akan, E.G., Kabalak, P.A., Kavurgac\u0131, S., Cengiz, T.I., Demira\u011f, F., Nomeno\u011flu, H., Ibi\u015f, H., and Y\u0131lmaz, \u00dc. (2024, January 7\u201311). The impact of visceral pleural invasion on survival in non-small cell lung cancer. Presented at the European Respiratory Society International Congress 2024, Vienna, Austria."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/18\/2944\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:31:20Z","timestamp":1789115480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/18\/2944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":32,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cancers18182944"],"URL":"https:\/\/doi.org\/10.3390\/cancers18182944","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]}}}